Privia Health Group, Inc. is 1.6x more valuable than GeneDx Holdings Corp. by market capitalization ($2.95 B vs $1.81 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PRVA | WGS |
|---|---|---|
| Market cap | $2.95 B | $1.81 B |
| US-listed rank | #1834 | #2177 |
| Revenue (latest FY) | $2.12B | $427.54M |
| Net income (latest FY) | $22.92M | -$21.00M |
| Net margin | 1.1% | -4.9% |
| P/E (trailing FY) | 128.7 | - |
| SEC filings | 580 | 748 |
Privia Health Group, Inc. is 1.6x more valuable than GeneDx Holdings Corp. by market capitalization ($2.95 B vs $1.81 B).
In their latest fiscal years, Privia Health Group, Inc. reported $2.12B in revenue while GeneDx Holdings Corp. reported $427.54M.
Full pages: Privia Health Group, Inc. and GeneDx Holdings Corp., or browse the full rankings.